Echo Street Capital Management LLC Biogen Inc. Transaction History

Echo Street Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $95,511 - $110,366	347 Added 22.53%	1,887 $537,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $873,843 - $995,710	-3,406 Reduced 68.86%	1,540 $428,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $708,094 - $860,349	2,805 Added 131.01%	4,946 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $416,831 - $574,772	2,141 New	2,141 $572,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $1.33 Million - $1.68 Million	-6,888 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.3 Million - $1.67 Million	5,793 Added 529.04%	6,888 $1.65 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $231,202 - $301,513	-817 Reduced 42.73%	1,095 $310,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $170,422 - $272,879	-658 Reduced 25.6%	1,912 $662,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $624,381 - $731,499	2,570 New	2,570 $719,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $2.6 Million - $3 Million	-9,827 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $2.54 Million - $3.37 Million	9,827 New	9,827 $2.63 Million

993

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.